Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05210556 · ClinicalTrials.gov registry record
Oral Antibiotic Bowel Preparation in Gynecologic Oncology Surgery
A clinical trial, sponsored by WellSpan Health.
- Completed
- Registry status
- 778
- Enrollment target
NCT05210556 is a clinical trial that has completed, run by WellSpan Health. The registered enrollment target is 778 participants.
The verdict
NCT05210556 has completed, sponsored by WellSpan Health.
- COMPLETED
- Registry status
- 778 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether the use of a preoperative antibiotic bowel regimen is associated with a reduced risk of deep organ/space surgical site infection in gynecologic oncology surgery.
Interventions
- OTHER Diagnosed with Surgical Site Infection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 778 participants |
| Start Date | 2021-12-22 |
| Est. Completion | 2024-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05210556
The ClinicalTrials.gov registry entry for NCT05210556 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 778 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is WellSpan Health, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diagnosed with Surgical Site Infection is the first listed.
NCT05210556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05210556 about?
NCT05210556 is a clinical study titled "Oral Antibiotic Bowel Preparation in Gynecologic Oncology Surgery". The purpose of this study is to investigate whether the use of a preoperative antibiotic bowel regimen is associated with a reduced risk of deep organ/space surgical site infection in gynecologic oncology surgery.
What is the current status of trial NCT05210556?
This trial is currently completed. The enrollment target is 778 participants. The study started on 2021-12-22. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT05210556?
The interventions under investigation include: Diagnosed with Surgical Site Infection (OTHER).
Who is sponsoring clinical trial NCT05210556?
This trial is sponsored by WellSpan Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.